Terms: = Ovarian cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
73 results:
1. Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
Lan T; Li Y; Wang Y; Wang ZC; Mu CY; Tao AB; Gong JL; Zhou Y; Xu H; Li SB; Gu B; Ma P; Luo L
Cell Death Dis; 2023 Jan; 14(1):39. PubMed ID: 36653376
[TBL] [Abstract] [Full Text] [Related]
2. Role of RAS signaling in ovarian cancer.
Therachiyil L; Anand A; Azmi A; Bhat A; Korashy HM; Uddin S
F1000Res; 2022; 11():1253. PubMed ID: 36451660
[TBL] [Abstract] [Full Text] [Related]
3. Circ_CDR1as: A circular RNA with roles in the carcinogenesis.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Sarfaraz S; Taheri M; Ayatollahi SA
Pathol Res Pract; 2022 Aug; 236():153968. PubMed ID: 35667198
[TBL] [Abstract] [Full Text] [Related]
4. Targeting EGFR, RSK1, raf1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study.
Bennani FE; Doudach L; Karrouchi K; Tarib A; Rudd CE; Ansar M; Faouzi MEA
J Biomol Struct Dyn; 2023 Jun; 41(9):4194-4218. PubMed ID: 35442150
[TBL] [Abstract] [Full Text] [Related]
5. DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment.
Nakkina SP; Gitto SB; Beardsley JM; Pandey V; Rohr MW; Parikh JG; Phanstiel O; Altomare DA
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947972
[TBL] [Abstract] [Full Text] [Related]
6. Low Expression of Rasal2 Promotes Non-small Cell Lung cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of ovarian malignancy in Bali province, Indonesia.
Budiana ING; Prayudi PKA; Saspriyana KY; Darmayasa IM; Wiradnyana AAG; Suwiyoga K
Med J Malaysia; 2021 May; 76(3):326-331. PubMed ID: 34031330
[TBL] [Abstract] [Full Text] [Related]
8. Specific Antiproliferative Properties of Proteinaceous Toxin Secretions from the Marine Annelid
Rodrigo AP; Mendes VM; Manadas B; Grosso AR; Alves de Matos AP; Baptista PV; Costa PM; Fernandes AR
Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33445445
[TBL] [Abstract] [Full Text] [Related]
9. KRAS K104 modification affects the KRAS
Chen CC; Hsu CY; Lin HY; Zeng HQ; Cheng KH; Wu CW; Tsai EM; Hsieh TH
Sci Rep; 2020 Oct; 10(1):17447. PubMed ID: 33060649
[TBL] [Abstract] [Full Text] [Related]
10. 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF
El-Damasy AK; Haque MM; Park JW; Shin SC; Lee JS; EunKyeong Kim E; Keum G
Eur J Med Chem; 2020 Dec; 208():112756. PubMed ID: 32942186
[TBL] [Abstract] [Full Text] [Related]
11. Systemic review on B-Raf
Chavda J; Bhatt H
Eur J Med Chem; 2020 Nov; 206():112675. PubMed ID: 32798788
[TBL] [Abstract] [Full Text] [Related]
12. Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.
Desai J; Gan H; Barrow C; Jameson M; Atkinson V; Haydon A; Millward M; Begbie S; Brown M; Markman B; Patterson W; Hill A; Horvath L; Nagrial A; Richardson G; Jackson C; Friedlander M; Parente P; Tran B; Wang L; Chen Y; Tang Z; Huang W; Wu J; Zeng D; Luo L; Solomon B
J Clin Oncol; 2020 Jul; 38(19):2140-2150. PubMed ID: 32182156
[TBL] [Abstract] [Full Text] [Related]
13. Zamzam water protects cancer cells from chemotherapy-induced apoptosis via mitogen-activated protein kinase-dependent pathway.
Siraj AK; Begum R; Melosantos R; Albalawy W; Abboud J; Siraj N; Al-Kuraya KS
Biomed Pharmacother; 2019 Oct; 118():109376. PubMed ID: 31545262
[TBL] [Abstract] [Full Text] [Related]
14. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract] [Full Text] [Related]
15. Human Epididymis Protein 4 Quantification and Interaction Network Analysis in Seminal Plasma.
Kant K; Tomar AK; Sharma P; Kundu B; Singh S; Yadav S
Protein Pept Lett; 2019 Jul; 26(6):458-465. PubMed ID: 30919767
[TBL] [Abstract] [Full Text] [Related]
16. Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
Sang B; Zhang YY; Guo ST; Kong LF; Cheng Q; Liu GZ; Thorne RF; Zhang XD; Jin L; Wu M
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11661-E11670. PubMed ID: 30478051
[TBL] [Abstract] [Full Text] [Related]
17. Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5.
Kleemann M; Schneider H; Unger K; Bereuther J; Fischer S; Sander P; Marion Schneider E; Fischer-Posovszky P; Riedel CU; Handrick R; Otte K
Cell Mol Life Sci; 2019 Feb; 76(3):539-559. PubMed ID: 30392041
[TBL] [Abstract] [Full Text] [Related]
18. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.
Kodama M; Kodama T; Newberg JY; Katayama H; Kobayashi M; Hanash SM; Yoshihara K; Wei Z; Tien JC; Rangel R; Hashimoto K; Mabuchi S; Sawada K; Kimura T; Copeland NG; Jenkins NA
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7301-E7310. PubMed ID: 28811376
[TBL] [Abstract] [Full Text] [Related]
19. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-raf.
Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
[TBL] [Abstract] [Full Text] [Related]
20. Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway.
Hu Y; Yang L; Yang Y; Han Y; Wang Y; Liu W; Zuo J
J Cell Mol Med; 2016 Nov; 20(11):2111-2121. PubMed ID: 27374312
[TBL] [Abstract] [Full Text] [Related]
[Next]
